Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, featuring promising developments across various healthcare and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, much more dependable different for therapeut